OppenheimerFunds’s Labcorp LH Stock Holding History

OppenheimerFunds’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$124M	Sell	946,077 -107,386	-10%	-$13.2M	0.15%	143
2018 Q4	$114M	Sell	1,053,463 -881,573	-46%	-$118M	0.16%	135
2018 Q3	$289M	Sell	1,935,036 -44,667	-2%	-$6.79M	0.34%	80
2018 Q2	$305M	Buy	1,979,703 +1,051,737	+113%	+$159M	0.36%	67
2018 Q1	$129M	Buy	927,966 +47,688	+5%	+$7M	0.16%	149
2017 Q4	$121M	Sell	880,278 -103,133	-10%	-$13.6M	0.15%	164
2017 Q3	$128M	Sell	983,411 -166,068	-14%	-$22.2M	0.16%	153
2017 Q2	$152M	Sell	1,149,479 -37,564	-3%	-$4.6M	0.19%	139
2017 Q1	$146M	Sell	1,187,043 -82,663	-7%	-$9.79M	0.18%	149
2016 Q4	$140M	Buy	1,269,706 +4,083	+0.3%	+$454K	0.18%	144
2016 Q3	$149M	Buy	1,265,623 +134,323	+12%	+$15.8M	0.19%	141
2016 Q2	$127M	Buy	1,131,300 +801,073	+243%	+$86.2M	0.17%	154
2016 Q1	$33.2M	Buy	330,227 +323,646	+4,918%	+$31M	0.04%	415
2015 Q4	$701K	Buy	+6,581	New	+$679K	﹤0.01%	1162

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

OppenheimerFunds's LH Position: Q1 2019 in Review

OppenheimerFunds reduced its Labcorp (LH) stake by 10% in Q1 2019, selling an estimated $13.2M and leaving 946,077 shares worth $124M. The position accounts for 0.15% of the portfolio, ranked #143.

OppenheimerFunds first reported a position in LH in Q4 2015 and has held it in 14 quarters since. The position peaked at $305M in Q2 2018. 745 funds tracked by Wall St. Rank hold LH as of Q1 2019.

OppenheimerFunds held 946,077 shares of Labcorp worth $124M as of Q1 2019.
OppenheimerFunds sold 107,386 Labcorp shares in Q1 2019, an estimated $13.2M.
Labcorp made up 0.15% of OppenheimerFunds's portfolio in Q1 2019, its #143 holding.
OppenheimerFunds first reported a position in Labcorp in Q4 2015 and has held it in 14 quarters since.
OppenheimerFunds's Labcorp position peaked at $305M in Q2 2018.
745 funds tracked by Wall St. Rank held Labcorp as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.